ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation

Clinical trial NCT01184300 · COMPLETED

Trial details

NCT number: NCT01184300
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stable Coronary Artery Disease Acute Coronary Syndrome Percutaneous Coronary Intervention

Start date: 2010-08-01
Primary completion: 2011-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.